Cameron Cunningham, MD
Pain Medicine · Charlotte, NCNPI 1275943011
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,711 of the $7,923 with a category attached, or 84.7%. 18 manufacturers reported payments, led by Abbott at 36.0% of the total.
Across 247 payments — averaging $32.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$2K
- Nevro Corp.$903
- SPR Therapeutics, Inc$852
- Medtronic$355
- Relievant Medsystems, Inc.$263
- plus $515 from 12 others
What the payments were for
- Travel & lodging$1,20015%
- Food & beverage$6,71185%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 82 | $2,850 |
| Boston Scientific | 93 | $2,185 |
| Nevro Corp. | 18 | $903 |
| SPR Therapeutics, Inc | 19 | $852 |
| Medtronic(2 entities) | 15 | $355 |
| Relievant Medsystems, Inc. | 3 | $263 |
| Nalu Medical, Inc. | 1 | $136 |
| Curonix LLC | 3 | $68 |
| Avanos Medical | 1 | $58 |
| Forte Bio-pharma LLC | 2 | $53 |
| AbbVie | 2 | $40 |
| Globus Medical | 1 | $30 |
| Painteq LLC | 2 | $30 |
| Biotronik NRO, Inc. | 1 | $29 |
| Vertos Medical, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,923 in reported general payments places this provider in the 70th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 29 | $17,739 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 376 | $11,609 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 388 | $8,942 |
| Xtampza ErOxycodone Myristate | 12 | $6,759 |
| Oxycodone Hcl | 221 | $4,248 |
| Diclofenac Sodium | 48 | $3,316 |
| Pregabalin | 125 | $2,611 |
| Fentanyl | 33 | $2,475 |
| Gabapentin | 130 | $2,389 |
| Naloxone Hcl | 32 | $2,224 |
| Lidocaine | 21 | $1,667 |
| Tramadol Hcl | 132 | $1,375 |
| Tizanidine Hcl | 70 | $745 |
| Morphine Sulfate | 20 | $729 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $707 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Charlotte
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- James DeeringCharlotte$93K
- Ankur ManvarCharlotte$33K
- Russell DavenportCharlotte$26K
- Gerald AronoffCharlotte$17K
- Raza KhanCharlotte$12K
- Alexander RothkrugCharlotte$10K
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.